Clinical Trial Update: Prophylactic Analgesia for Bladder Botox Injections [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating prophylactic analgesia for bladder Botox injections has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urge Incontinence
• Urinary Incontinence

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Montefiore Medical Center | Conditions: Urinary Incontinence, Urinary Incontinence, Urge | Phase 4 | Status: WITHDRAWN